Beyond Xerostomia: A Two-Year Follow-Up Case Report of Periodontal and Peri-Implant Health in Primary Sjögren Syndrome
- 1Faculty of Dental Medicine, Saint Joseph University of Beirut, Beirut, LBN
- 2Department of Oral Medicine and Radiology, Saint Joseph University of Beirut, Beirut, LBN
- 3Cranio-Facial Research Laboratory, Department of Oral Pathology, Saint Joseph University of Beirut, Beirut, LBN
Abstract
Primary Sjögren syndrome (pSS) is an autoimmune disorder characterized by chronic salivary gland dysfunction that predisposes patients to oral complications and tooth loss. Although dental implant therapy has demonstrated favorable survival rates in patients with pSS, evidence regarding long-term peri-implant soft tissue health remains limited. This report describes the diagnosis of pSS following implant rehabilitation and highlights the impact of the disease on peri-implant health during a two-year follow-up. A 61-year-old man underwent implant placement at sites 14 and 16 with simultaneous sinus floor elevation and connective tissue grafting. Several months later, he developed progressive xerostomia, xerophthalmia, burning mouth symptoms, and dysphagia. Histopathological examination of a minor labial salivary gland biopsy revealed focal lymphocytic sialadenitis (Chisholm and Mason grade 3), with findings considered compatible with Sjögren syndrome in the clinical context. Following rheumatologic management with hydroxychloroquine and pilocarpine, the patient was monitored for two years. Clinical examination demonstrated persistent xerostomia and generalized gingival and peri-implant mucosal inflammation, whereas radiographic evaluation showed stable peri-implant bone levels without marginal bone loss. This case supports current evidence indicating that implant osseointegration and short-term survival can be maintained in patients with pSS despite chronic hyposalivation. However, it also illustrates that persistent salivary dysfunction and immune dysregulation may predispose peri-implant tissues to mucosal inflammation in the absence of radiographic bone loss, emphasizing that peri-implant tissue health should be evaluated independently of implant survival. Dental implants appear to represent a reliable rehabilitation option for patients with pSS when combined with individualized supportive care. Nevertheless, long-term success should be assessed not only by implant survival and marginal bone stability but also by careful monitoring of peri-implant soft tissue health. Early recognition of Sjögren syndrome by dental practitioners and multidisciplinary management are essential for optimizing both systemic and implant-related outcomes.
Related
- Pulmonary Dysfunction Contributes to Nocturnal Hypoxemia Beyond Obstructive Sleep Apnea Severity in Primary Sjögren Syndrome
- Intraglandular treatment with adipose-derived mesenchymal stem cells in patients with xerostomia due to Sjögren’s disease—a study protocol for aphase 1, triple-blinded, randomized, clinical trial
- Kidney Involvement in Primary Sjögren Syndrome: Focus on Tubulointerstitial Nephritis
- Clinical, immunological, and radiological characteristics of pulmonary involvement in childhood-onset primary Sjögren’s syndrome: a single-center retrospective study
- Evaluation of factors affecting physical activity and physical function in women with primary sjogren syndrome
BibTeX
@article{nammour2026beyond,
title = {{Beyond Xerostomia: A Two-Year Follow-Up Case Report of Periodontal and Peri-Implant Health in Primary Sjögren Syndrome}},
author = {Joey Nammour and Elsa Boustany and Samar Bou Jaoude and Ghassan Yared and Wassim Manhal},
journal = {Cureus},
year = {2026},
month = oct,
doi = {10.7759/cureus.117413},
url = {https://europepmc.org/article/PMC/PMC13728483},
note = {CC BY},
}
RIS
TY - JOUR
TI - Beyond Xerostomia: A Two-Year Follow-Up Case Report of Periodontal and Peri-Implant Health in Primary Sjögren Syndrome
AU - Joey Nammour
AU - Elsa Boustany
AU - Samar Bou Jaoude
AU - Ghassan Yared
AU - Wassim Manhal
PY - 2026
DA - 2026/10/04
JO - Cureus
DO - 10.7759/cureus.117413
UR - https://europepmc.org/article/PMC/PMC13728483
AB - Primary Sjögren syndrome (pSS) is an autoimmune disorder characterized by chronic salivary gland dysfunction that predisposes patients to oral complications and tooth loss. Although dental implant therapy has demonstrated favorable survival rates in patients with pSS, evidence regarding long-term peri-implant soft tissue health remains limited. This report describes the diagnosis of pSS following implant rehabilitation and highlights the impact of the disease on peri-implant health during a two-year follow-up. A 61-year-old man underwent implant placement at sites 14 and 16 with simultaneous sinus floor elevation and connective tissue grafting. Several months later, he developed progressive xerostomia, xerophthalmia, burning mouth symptoms, and dysphagia. Histopathological examination of a minor labial salivary gland biopsy revealed focal lymphocytic sialadenitis (Chisholm and Mason grade 3), with findings considered compatible with Sjögren syndrome in the clinical context. Following rheumatologic management with hydroxychloroquine and pilocarpine, the patient was monitored for two years. Clinical examination demonstrated persistent xerostomia and generalized gingival and peri-implant mucosal inflammation, whereas radiographic evaluation showed stable peri-implant bone levels without marginal bone loss. This case supports current evidence indicating that implant osseointegration and short-term survival can be maintained in patients with pSS despite chronic hyposalivation. However, it also illustrates that persistent salivary dysfunction and immune dysregulation may predispose peri-implant tissues to mucosal inflammation in the absence of radiographic bone loss, emphasizing that peri-implant tissue health should be evaluated independently of implant survival. Dental implants appear to represent a reliable rehabilitation option for patients with pSS when combined with individualized supportive care. Nevertheless, long-term success should be assessed not only by implant survival and marginal bone stability but also by careful monitoring of peri-implant soft tissue health. Early recognition of Sjögren syndrome by dental practitioners and multidisciplinary management are essential for optimizing both systemic and implant-related outcomes.
SN - 2168-8184
ER -